Fig. 1: The impact of cytogenetic risk on allogeneic stem cell transplantation outcomes in patients with secondary acute myeloid leukemia.

a (aGVHD>=II) acute graft versus hose disease grade II-IV; b (aGVHD>=III) acute graft versus hose disease grade III-IV; c (cGVHD) all grades chronic graft versus host disease; d (extcGVHD) extensive chronic graft versus host disease.